The known clinical features favoring a metastatic tumor into the ovary include history of an antecedent malignancy, relatively smaller size of the tumor ~10 cms, solid structure, frequent bilaterality; absence of ascites and elevated serum carcinoembryonic antigen (CEA) levels [1]. Here, CEACAM5 is linked to metastatic neoplasm.